The private equity firm Inflexion has agreed to acquire German medical consumables manufacturer Primed Group from Paragon Partners, in a deal the pair said was aimed at accelerating the company's international expansion and strengthening its position in the global single-use medical device market.
The companies did not disclose the financial terms of the transaction, but the deal is rumoured to be around €300m.
Founded in 1946 and headquartered in Halberstadt, Germany, Primed designs, manufactures and distributes certified single-use medical consumables for hospitals and healthcare providers.
The company employs more than 450 people and operates a vertically integrated manufacturing model spanning raw material compounding through to sterile finished products, supplying customers in more than 70 countries.
Alongside its medical device manufacturing operations, Primed owns HA2, one of Europe's largest medical sterilisation platforms, giving the business additional capabilities in outsourced sterilisation services as demand for sterile, single-use medical products continues to grow.
The investment will be made through Inflexion's Buyout Fund VI and marks the firm's sixth investment in the DACH region and its third healthcare investment there.
Following completion, Inflexion said that it plans to support Primed's growth through investment in product development, expansion of its sterilisation business and targeted acquisitions designed to strengthen its commercial presence in key international markets.
For pharmaceutical and medical device manufacturers, the acquisition reflects continued investor confidence in businesses with integrated manufacturing capabilities and critical sterilisation infrastructure.
Regulatory requirements under the EU Medical Device Regulation (MDR), together with rising demand for infection prevention and single-use devices, have increased the strategic importance of manufacturers able to control production and sterilisation across the value chain.
To support the next phase of growth, healthcare executives Wolfgang Suessle, former CEO and President of Lohmann & Rauscher and medical device entrepreneur Justin Barnes will join Primed's Board of Directors, bringing extensive experience in scaling international healthcare businesses.
Daniel Schiel, CEO of Primed Group, said: "We are delighted to welcome Inflexion as our new partner. They share our long-term vision for Primed and HA2 and bring significant experience in supporting ambitious businesses through their next phase of growth."
Together, we look forward to building on Primed's strong German heritage as we continue to expand internationally, invest in innovation and deliver high-quality products to hospitals and medical facilities worldwide.
Flor Kassai, Managing Partner and Head of Buyout at Inflexion, added that Primed's integrated business model, established product portfolio and long-standing customer relationships provide "a strong platform" for the company's next stage of international growth.
